Literature DB >> 9539227

A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons.

L Liu1, A Szallasi, S A Simon.   

Abstract

Capsaicin, the vanilloid responsible for the pungent taste of hot peppers, binds to receptors found primarily in polymodal nociceptors. Capsaicin initially stimulates polymodal nociceptors and subsequently inhibits them from responding to a variety of stimuli. This property makes it useful clinically as an analgesic and anti-inflammatory compound. There is mounting, albeit indirect, evidence for the existence of several subtypes of vanilloid receptors. One such piece of evidence comes from studying analogues of capsaicin, such as phorbol 12-phenylacetate 13 acetate 20-homovanillate. This compound binds to (capsaicin) vanilloid receptors on sensory neurons, but unlike capsaicin it is non-pungent and does not produce hypothermia. To determine how sensory neurons respond to phorbol 12-phenylacetate 13 acetate 20-homovanillate, and to compare these responses with those evoked by capsaicin, whole-cell patch-clamp measurements were performed on cultured rat trigeminal ganglion neurons. It was found that 63% of the neurons held at -60 mV were activated by 3 microM, phorbol 12-phenylacetate 13 acetate 20-homovanillate, and 87% of these were also activated by 1 microM capsaicin. In a given neuron, phorbol 12-phenylacetate 13 acetate 20-homovanillate, like capsaicin, could activate kinetically distinct inward currents. The current-voltage curves characterizing phorbol 12-phenylacetate 13 acetate 20-homovanillate responses were asymmetric and had reversal potentials at -5.8 +/- 6.0 mV and 10.4 +/- 4 mV. The averaged dose-response curves for phorbol 12-phenylacetate 13 acetate 20-homovanillate were fit to the Hill equation and had binding constants (K(1/2)s) of 2.73 microM and 0.96 microM and Hill coefficients (ns) of approximately 1 for a rapidly- and slowly-activating current, respectively. These parameters are consistent with those obtained from binding experiments and calcium-influx experiments on sensory nerves. Repeated applications of phorbol 12-phenylacetate 13 acetate 20-homovanillate every 3 min caused a complete reduction in the rapidly-activating currents leaving only a reduced slowly-activating current. This provides strong evidence for the independence of these currents and the existence of subtypes of vanilloid receptors. Additional evidence for the existence of receptor subtypes is that 10 microM capsazepine, a specific and competitive inhibitor of capsaicin-evoked responses, did not inhibit the phorbol 12-phenylacetate 13 acetate 20-homovanillate-induced currents in some neurons and partially inhibited them in other neurons. Thus, there are capsazepine-sensitive and capsazepine-insensitive subtypes of vanilloid receptors. In summary, we have obtained electrophysiological and pharmacological evidence for distinct subtypes of vanilloid receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539227     DOI: 10.1016/s0306-4522(97)00523-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  14 in total

1.  A study of the voltage dependence of capsaicin-activated membrane currents in rat sensory neurones before and after acute desensitization.

Authors:  A S Piper; J C Yeats; S Bevan; R J Docherty
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

2.  Functional and desensitizing effects of the novel synthetic vanilloid-like agent 12-phenylacetate 13-acetate 20-homovanillate (PPAHV) in the perfused rat hindlimb.

Authors:  C D Griffiths; M A Vincent; A Szallasi; E Q Colquhoun; D P Geraghty
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide.

Authors:  Dominic P Geraghty; Stuart B Mazzone
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Development of nociceptive synaptic inputs to the neonatal rat dorsal horn: glutamate release by capsaicin and menthol.

Authors:  Mark L Baccei; Rita Bardoni; Maria Fitzgerald
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

5.  A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors.

Authors:  A Szallasi; T Bíró; T Szabó; S Modarres; M Petersen; A Klusch; P M Blumberg; J E Krause; O Sterner
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Cannabinoid receptor antagonists AM251 and AM630 activate TRPA1 in sensory neurons.

Authors:  Mayur Patil; Amol Patwardhan; Margaux M Salas; Kenneth M Hargreaves; Armen N Akopian
Journal:  Neuropharmacology       Date:  2011-05-27       Impact factor: 5.250

7.  Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors.

Authors:  S B Mazzone; D P Geraghty
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Pharmacological differences between the human and rat vanilloid receptor 1 (VR1).

Authors:  P McIntyre; L M McLatchie; A Chambers; E Phillips; M Clarke; J Savidge; C Toms; M Peacock; K Shah; J Winter; N Weerasakera; M Webb; H P Rang; S Bevan; I F James
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

9.  Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.

Authors:  Theodore J Price; Amol Patwardhan; Armen N Akopian; Kenneth M Hargreaves; Christopher M Flores
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

10.  Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation.

Authors:  Masahiro Nagahama; Shinsuke Morimitsu; Atsushi Kihara; Masahiko Akita; Koujun Setsu; Jun Sakurai
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.